PET and [18F]-FDG in oncology: A clinical update
- 31 August 1996
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (6), 717-735
- https://doi.org/10.1016/0969-8051(96)00074-1
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- Positron emission tomography: 2-deoxy-2-Z18F]-fluoro-d-glucose uptake in locally advanced breast cancersEuropean Journal of Surgical Oncology, 1995
- Positron emission tomography: a financial and operational analysis.American Journal of Roentgenology, 1994
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapyJournal of Clinical Endocrinology & Metabolism, 1993
- Positron Emission Tomography of Thyroid MassesThyroid®, 1993
- Second Thoughts about Second-Look Laparotomy in Advanced Ovarian CancerNew England Journal of Medicine, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Patterns of pelvic recurrence following definitive resections of rectal cancerCancer, 1984
- Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomographyThe American Journal of Cardiology, 1979